title: Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
abstract: Case histories of three Rhodesian sleeping sickness patients who relapsed after Mel-B therapy are presented. Repeated Mel-B therapy was clinically effective but not curative, and all three patients subsequently relapsed again and required further treatment.
authors.affiliation: Walter Reed Project, Kenya Medical Research Institute, Nairobi.
authors.forename: J D
authors.initials: JD
authors.lastname: Bales
authors.forename: S M
authors.initials: SM
authors.lastname: Harrison
authors.forename: D L
authors.initials: DL
authors.lastname: Mbwabi
authors.forename: P J
authors.initials: PJ
authors.lastname: Schecter
mesh_terms: D000328:Adult; D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007630:Kenya; D008297:Male; D008549:Melarsoprol / Q000627:therapeutic use*; D008875:Middle Aged; D012008:Recurrence; D013498:Suramin / Q000627:therapeutic use; D014346:Trypanosoma brucei brucei; D014353:Trypanosomiasis, African / Q000188:drug therapy*
chemical_list: D001152:Arsenicals; D013498:Suramin; D008549:Melarsoprol; D000518:Eflornithine